Michael Carruthers is CFO at ARRAY BIOPHARMA INC (ARRY). They have made 3 open-market trades across 1 company since 2006, most recently 2013-07-24.
CIK 0001184335
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARRY | 112,265 | $383K |
Shares reported on the most recent Form 4, priced at the 2013-07-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARRY | SELL · 10b5-1 | 2012-02-10 | 2012-02-10 | $2.65 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2012-01-12 | 2012-01-12 | $2.06 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-12-12 | 2011-12-12 | $2.35 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-11-11 | 2011-11-14 | $2.47 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-10-12 | 2011-10-12 | $2.08 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-09-12 | 2011-09-14 | $2.02 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-08-12 | 2011-08-15 | $2.26 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-07-12 | 2011-07-12 | $2.50 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-06-10 | 2011-06-13 | $2.38 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-05-12 | 2011-05-12 | $2.75 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-04-12 | 2011-04-12 | $3.04 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-03-11 | 2011-03-16 | $3.11 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-02-11 | 2011-02-11 | $2.91 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2011-01-12 | 2011-01-13 | $3.20 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-12-10 | 2010-12-10 | $3.24 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-11-12 | 2010-11-12 | $3.33 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-10-12 | 2010-10-13 | $3.32 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-09-14 | 2010-09-15 | $2.88 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-08-23 | 2010-08-24 | $2.79 | $47 | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-07-23 | 2010-07-23 | $3.11 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-06-23 | 2010-06-23 | $3.37 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-05-21 | 2010-05-25 | $3.44 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-04-23 | 2010-04-26 | $3.78 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-03-23 | 2010-03-24 | $2.46 | $4K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL · 10b5-1 | 2010-02-23 | 2010-02-24 | $2.40 | $4K | +33.9% | +23.6% | +23.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.